Correlation Between Health Biotchnology and Morgan Stanley

Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Health Biotchnology Portfolio and Morgan Stanley Multi, you can compare the effects of market volatilities on Health Biotchnology and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Morgan Stanley.

Diversification Opportunities for Health Biotchnology and Morgan Stanley

-0.03

Correlation Coefficient

Health Biotchnology  Morgan Stanley

Good diversification

The 3 months correlation between Health and Morgan is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Morgan Stanley Multi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley Multi and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley Multi has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Morgan Stanley go up and down completely randomly.

Pair Corralation between Health Biotchnology and Morgan Stanley

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to generate 0.36 times more return on investment than Morgan Stanley. However, Health Biotchnology Portfolio is 2.81 times less risky than Morgan Stanley. It trades about 0.08 of its potential returns per unit of risk. Morgan Stanley Multi is currently generating about -0.07 per unit of risk. If you would invest  2,283  in Health Biotchnology Portfolio on December 21, 2024 and sell it today you would earn a total of  77.00  from holding Health Biotchnology Portfolio or generate 3.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Health Biotchnology Portfolio  vs.  Morgan Stanley Multi

Health Biotchnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Health Biotchnology Portfolio are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Morgan Stanley Multi

Risk-Adjusted Performance

Very Weak

Over the last 90 days Morgan Stanley Multi has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Health Biotchnology and Morgan Stanley

The main advantage of trading using opposite Health Biotchnology and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.

The idea behind Health Biotchnology Portfolio and Morgan Stanley Multi pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.